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Introduction
Asthma is a common condition in general medical prac-
tice, accounting for about 1% of all ambulatory visits in the
USA [1]. The mortality rate from asthma has risen sharply
since the late 1970s, which may reflect increasing disease
severity [2]. The hospitalization rate, another population-
level marker of asthma severity, remains substantial [2],
generating nearly one-half of all US health care costs for
asthma [3]. Hospitalization rates for asthma have actually
increased in some demographic subgroups, such as
young adults [2] and the urban poor [4], despite recent
therapeutic advances. Understanding the factors underlying
hospitalization for asthma could help elucidate the recent
rise in asthma morbidity.
Abstract
Background: The morbidity and mortality from asthma have markedly increased since the late 1970s.
The hospitalization rate, an important marker of asthma severity, remains substantial.
Methods: In adults with health care access, we prospectively studied 242 with asthma, aged
18–50 years, recruited from a random sample of allergy and pulmonary physician practices in Northern
California to identify risk factors for subsequent hospitalization.
Results: Thirty-nine subjects (16%) reported hospitalization for asthma during the 18-month follow-up
period. On controlling for asthma severity in multiple logistic regression analysis, non-white race (odds
ratio [OR], 3.1; 95% confidence interval [CI], 1.1–8.8) and lower income (OR, 1.1 per $10,000
decrement; 95% CI, 0.9–1.3) were associated with a higher risk of asthma hospitalization. The
severity-of-asthma score (OR, 3.4 per 5 points; 95%, CI 1.7–6.8) and recent asthma hospitalization
(OR, 8.3; 95%, CI, 2.1–33.4) were also related to higher risk, after adjusting for demographic
characteristics. Reliance on emergency department services for urgent asthma care was also
associated with a greater likelihood of hospitalization (OR, 3.2; 95% CI, 1.0–9.8). In multivariate
analysis not controlling for asthma severity, low income was even more strongly related to
hospitalization (OR, 1.2 per $10,000 decrement; 95% CI, 1.02–1.4).
Conclusion: In adult asthmatics with access to health care, non-white race, low income, and greater
asthma severity were associated with a higher risk of hospitalization. Targeted interventions applied to
high-risk asthma patients may reduce asthma morbidity and mortality.
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Previous studies have identified several factors that con-
tribute to increased hospitalization risk among adults with
asthma. Demographic characteristics, such as poverty, low
educational attainment, female gender, and African–Ameri-
can race, have been associated with a greater risk of hospi-
talization for asthma [2,4–11]. Poor health care access and
inadequate preventive asthma care have also been fre-
quently cited as contributing factors [5,12–15]. In these
studies, however, separating the independent effects of
demographic characteristics, health care access, and
disease severity has been difficult. For instance, the associ-
ation between low income or non-white race and greater
asthma hospitalization risk is potentially confounded by
inadequate health care access. Because many studies rely
on ecologic socioeconomic and hospitalization data, indi-
vidual-level factors — especially asthma severity — cannot
be adequately examined [4–8,15–18]. Other studies have
not yet provided prospective follow-up [9,10,19,20] or
have not simultaneously considered both demographic and
clinical variables [21,22].
In this article, using a prospective cohort study of adults
with asthma, we delineate the relative impact of demo-
graphic characteristics and asthma severity on subse-
quent hospitalization for asthma. Since study subjects
were recruited from a random sample of physician prac-
tices, they all had access to health care for asthma. As a
result, we could evaluate the effects of gender, race,
income, and asthma severity on hospitalization, indepen-
dent of health care access.
Materials and methods
Subject recruitment and retention
We used data collected during a prospective, longitudinal
cohort study of adults with asthma recruited from physi-
cian practices in Northern California. Details of the study
design have been previously reported [23–26]. Each
subject underwent a structured, computer-assisted tele-
phone interview covering demographic characteristics,
smoking history, asthma history, symptoms, and treatment,
health status, health care utilization for asthma, and insur-
ance for asthma care.
Physicians registered 669 eligible patients. After initial
data collection at baseline (n = 601) and 18-month follow-
up interviews (n = 539), we later restricted the data set to
371 of the baseline cohort (55% of total registry) and 242
of the follow-up subjects (65% of restricted baseline
cohort). We restricted the data set to eliminate all inter-
views potentially compromised by faulty data collection or
documentation by a single survey interviewer [26,27]. This
restricted data set excluded 24 baseline subjects who
were found to be outside the study age range and 206
baseline subjects with inconsistent data during subse-
quent re-interview. Of the 371 baseline subjects, the present
study excludes an additional 129 subjects at 18-month
follow-up interview who had inconsistent data at later
interviews or did not complete follow-up, leaving 242
follow-up interviews (18 month). These exclusions had no
significant effect on study findings.
Demographic data for comparison of the baseline cohort
(n = 371) with registered subjects (n = 669) are not avail-
able. Compared with subjects who participated in both
baseline and follow-up interviews (n = 242), subjects
without complete follow-up interviews (n = 129) were
younger (36.6 years versus 40.5 years) and less likely to
have white race/ethnicity (62% versus 71%; P < 0.001
and P = 0.10, respectively). There were no statistical dif-
ferences in history of ever smoking (43% of participants in
both interviews versus 37% of non-participants at follow-
up), female gender (73% versus 66%), atopic history
(82% versus 83%), or severity-of-asthma scores (11.0
versus 10.6; P > 0.15 in all cases).
Hospitalization for asthma
The primary study outcome was self-reported hospitaliza-
tion for asthma during the 18-month prospective follow-up
period. Subjects were asked at 18-month follow-up inter-
views whether they had been hospitalized for asthma
during the previous 18 months. Although subjects could
indicate more than one positive response, we analyzed the
binary outcome of one or more hospitalization for asthma.
Risk factor variables
All demographic variables were based on baseline subject
interview responses. Current and prior cigarette smoking
history was assessed using questions adapted from the
National Health Interview Survey [28].
We previously developed and validated a 13-item disease-
specific severity-of-asthma score with four subscales: fre-
quency of current asthma symptoms (daytime or
nocturnal), use of systemic corticosteroids, use of other
asthma medications (besides systemic corticosteroids),
and history of hospitalizations and intubations [23–25].
Possible total scores range from 0 to 28, with higher
scores reflecting more severe asthma. To examine the rel-
ative impact of recent and remote hospitalization on
further hospitalization for asthma over longitudinal follow-
up, we removed hospitalization from the established sever-
ity score and defined two new variables: recent
hospitalization (during the 12 months prior to baseline
interview), or remote hospitalization (past hospitalization
not meeting the previous definition of recent). As a result,
the hospitalization and intubation subscale now reflects
only prior history of intubation.
Several other clinical aspects of asthma were assessed.
We defined asthma onset as the subject-reported age of
first asthma symptoms. Atopic history was defined by a
reported history of allergic rhinitis or atopic dermatitis.c
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Because prior work suggests an unexpectedly high preva-
lence of aspirin intolerance in persons with near fatal
asthma [29], we ascertained any history of aspirin sensitiv-
ity at baseline interview. Since gastroesophageal reflux
disease (GERD) may exacerbate asthma symptoms [30],
we evaluated whether subjects were taking H2-blockers
or proton pump inhibitors as surrogates for GERD and
related conditions. We furthermore determined whether
subjects possessed a peak flow meter for home usage.
Generic health status was measured using the Medical
Outcomes Study SF-36 questionnaire [31,32]. We
assessed several indicators of health care access for
asthma care, including whether subjects had a regular site
for asthma care, a principal care provider for asthma,
medical insurance for outpatient asthma care, and an
annual deduction for outpatient medical care. We also
identified subjects who appeared to rely on emergency
department (ED) services for urgent asthma care. We
defined reliance on ED care as one or more self-reported
ED visits during the interview interval but no urgent outpa-
tient clinic or office visits for asthma, either to regular or
alternate sources of asthma care.
Statistical analysis
In a previous analysis of pulmonary and allergy specialist
care, the severity-of-asthma score was associated with an
increased risk of hospitalization at 18-month follow-up
[25]. The current study evaluates other risk factors for
asthma-related hospitalization, taking baseline asthma
severity into account. Because asthma severity may act on
the causal pathway between a risk factor and subsequent
hospitalization for asthma, we present multivariate models
both including and excluding baseline asthma severity and
generic health status. For example, low education could
increase the risk of hospitalization either directly, through
poor self-management strategies, or indirectly, if poorly
educated persons have greater asthma severity for other
reasons. We also delineate the components of asthma
severity — respiratory symptoms, systemic corticosteroid
use, other asthma medication use, past intubations, and
previous hospitalizations — that are most strongly predic-
tive of subsequent hospitalization.
Interview data were analyzed using SAS 6.12 software
(SAS Institute, Cary, NC, USA). We evaluated the associ-
ation between baseline characteristics and the risk of hos-
pitalization for asthma during the ensuing 18-month
follow-up period, reported at the 18-month interview. We
use the data set restricted to 242 subjects with verified
baseline and follow-up interviews for all analyses.
Bivariate relationships were examined using logistic
regression analysis, with separate models for each predic-
tor variable. We used multiple logistic regression analysis
to elucidate the independent association between each
baseline variable and the prospective risk of hospitaliza-
tion. In constructing the multivariate model, all predictor
variables whose bivariate odds ratio and 95% confidence
interval suggested a possible association with hospitaliza-
tion were entered into the final model. All variables
deemed important on an a priori basis, such as age, were
also included.
Results
Health care access
Reflecting the sampling method employed, all subjects
identified a regular source of asthma care and a primary
medical provider for asthma care at baseline interview.
The majority of participants (97%) also reported having
health insurance covering outpatient visits for asthma.
Approximately one-third of subjects indicated having
annual insurance deductible for physician visits (31%).
The majority of subjects continued to report health insur-
ance coverage (96%) and ongoing primary asthma care
(99%) at 18-month follow-up. Despite apparent access to
outpatient medical care, a substantial proportion (16%)
appeared to rely on the ED for urgent asthma care.
Demographic factors and the risk of hospitalization:
bivariate analysis
Table 1 shows that the mean baseline age was 40.5 years
and the majority of subjects were female (73%). A substan-
tial proportion reported ever smoking cigarettes (43%), with
fewer indicating current smoking (7%). The majority of sub-
jects indicated white, non-Hispanic race/ethnicity (71%).
Thirty-nine subjects (16%) reported at least one hospital-
ization for asthma during the prospective 18-month follow-
up period. Of the baseline characteristics, non-white race
(OR, 2.1; 95% CI, 1.1–4.0) and lower income (OR, 1.3;
95% CI, 1.1–1.5) were associated with a greater risk of
hospitalization for asthma during the 18-month follow-up
(Table 1). Current smokers had an increased likelihood of
hospitalization, although the confidence interval did not
exclude no association. Greater educational attainment
was related to a lower risk of hospitalization (OR, 0.8 per
year of education; 95% CI, 0.70–0.96).
Clinical risk factors for hospitalization: bivariate analysis
A greater severity-of-asthma score, excluding its hospital-
ization component, was associated with a higher risk of
subsequent hospitalization for asthma (OR, 4.7 per 5-
point score increment; 95% CI, 2.9–7.7) (Table 2).
Although remote asthma hospitalization did not appear
related to risk of ensuing hospitalization, more recent hos-
pitalization was strongly associated with increased risk
(OR, 11.6; 95% CI, 5.3–25.2). Other clinical variables
that may reflect exacerbating factors, such as aspirin
allergy and use of gastric acid suppression medication,
were also associated with a greater risk of asthma hospi-
talization.
Available online http://respiratory-research.com/content/2/1/053Better baseline generic physical health status (SF-36) was
associated with a slightly decreased risk of subsequent
hospitalization (6% reduction in odds per 1 point score
increment; 95% CI, 3–9%) (Table 2). Mental health status
was furthermore associated with a 4% reduction in the risk
of hospitalization per 1 point (95% CI, 0–7%). Reliance on
emergency department care was finally related to a greater
risk of hospitalization (OR, 2.5; 95% CI, 1.1–5.5).
Risk of hospitalization — multivariate analysis
We examined the independent impact of selected covari-
ates on the prospective risk of hospitalization for asthma
using multiple logistic regression analysis (Table 3). Of the
demographic characteristics, non-white race was associ-
ated with a greater risk of subsequent asthma hospitaliza-
tion (OR, 3.1; 95% CI, 1.1–8.8) after controlling for
asthma severity and the other covariates shown. Lower
household income was also related to a greater risk of
hospitalization (OR 1.1 per $10,000 decrement), although
the 95% confidence interval did not exclude no relation to
hospitalization (0.9–1.3). Controlling for demographic and
other variables, greater severity-of-asthma score (OR, 3.4
per 5-point increment; 95% CI, 1.7–6.8) and recent hos-
pitalization for asthma (OR, 8.3; 95% CI, 2.1–33.4) were
strongly associated with an increased risk of hospitaliza-
tion. Reliance on ED for urgent asthma care was also
related to greater risk.
We examined the relation between race and hospitaliza-
tion in more detail. African–American race was associated
with an increased risk of hospitalization for asthma, com-
pared with white, non-Hispanic persons, after controlling
for covariates (OR, 10.2; 95% CI, 1.8–58.4). Hispanic
race/ethnicity also appeared related to hospitalization
(OR, 4.0; 95% CI, 0.9–18.0). There was no apparent rela-
tion between Asian race and risk of hospital admission
(OR, 2.0; 95% CI, 0.4–10.9).
To further examine the association between asthma sever-
ity and hospitalization, we repeated the multivariate analy-
sis dividing the overall severity-of-asthma score into its
Respiratory Research    Vol 2 No 1 Eisner et al
Table 1
Risk factors for hospitalization over longitudinal follow-up:
demographic characteristics and smoking
Baseline Risk  of 
interview hospitalization at 
(mean [SD] 18 months
Risk factor or n [%]) (OR [95% CI])
Age (per 10 years) 40.5 (7.3) 1.0 (0.6–1.7)
Female gender 177 (73%) 1.1 (0.5–2.4)
Non-white race/ethnicity 71 (29%) 2.1 (1.1–4.0)
Education (years) 14.9 (2.5) 0.8 (0.70–0.96)
Household income* 45,000 1.3 (1.1–1.5)
Married or cohabitating 160 (66%) 1.0 (0.5–2.1)
Current cigarette smoking 18 (7%) 2.1 (0.7–6.4)
Past cigarette smoking 87 (36%) 1.3 (0.6–2.6)
Bivariate analysis (n = 242). *Median household income (25th–75th
interquartile range, $25,000–$62,500); odds ratio per $10,000
decrement.
Table 2
Risk factors for hospitalization over longitudinal follow-up: clinical factors, asthma severity, health status, and health care access
Baseline interview Risk of hospitalization at 18 months 
Risk factor (mean [SD] or n [%]) (OR [95% CI])
Asthma severity
Severity-of-asthma score (per 5 points) 11.1 (4.8) 4.7 (2.9–7.7)
Recent hospitalizations for asthma* 60 (25%) 11.6 (5.3–25.2)
Remote hospitalizations for asthma† 64 (26%)  0.7 (0.3–1.6)
Other asthma clinical factors
Childhood onset (before 18 years) 117 (48%) 1.0 (0.5–2.0)
Atopic history 199 (82%) 0.5 (0.2–1.1)
Aspirin allergy history 32 (13%) 2.3 (1.0–5.6)
Gastric acid suppression medication (in prior 12 months) 62 (26%) 2.7 (1.3–5.5)
Generic health status
SF-36 Physical component score (per 1 point) 43.1 (12.0) 0.94 (0.91–0.97)
SF-36 Mental component score (per 1 point) 44.3 (9.2) 0.96 (0.93–1.0)
Health care access
Deductable for physician office visits 76 (31%) 1.0 (0.5–2.0)
Reliance on ED for urgent asthma care 39 (16%) 2.5 (1.1–5.5)
Bivariate analysis (n = 242). ED, emergency department. *Recent hospitalizations, hospitalization during 12 months prior to baseline interview or
18 months prior to 18-month follow-up interview. †Remote hospitalizations, hospitalization more than 12 months prior to baseline interview.four subscales. The systemic corticosteroid score (OR,
1.7 per 5-point score increment; 95% CI, 1.3–2.3) and
recent hospitalization for asthma (OR, 9.7; 95% CI,
2.2–43.0) were significantly associated with an increased
risk of asthma hospitalization, after controlling for covari-
ates. There was, conversely, no statistical relationship
between other asthma medications (OR, 1.1; 95% CI,
0.8–1.6) or asthma symptom scores (OR, 1.2; 95% CI,
0.7–1.9) and the ensuing risk of hospitalization. Systemic
corticosteroid use and recent asthma hospitalization, then,
appear to drive the relationship between asthma severity
and hospitalization for asthma.
Because asthma severity could act as a causal intermedi-
ate between a risk factor and the risk of hospitalization,
we repeated the multivariate analysis excluding asthma
severity and generic health status from the model
(Table 3). In this analysis, low income was more strongly
related to a greater risk of hospitalization for asthma (OR,
1.2; 95% CI, 1.02–1.4). Use of gastric acid suppression
therapy was also associated with increased risk (OR, 2.2;
95% CI, 1.0–4.9). Although other point estimates and
confidence intervals changed slightly, there were no other
notable changes compared with the model controlling for
asthma severity.
To examine whether subjects without baseline health
insurance coverage (3%) were affecting study results, we
repeated the multivariate analysis excluding these sub-
jects. Only one of the 39 subjects hospitalized at follow-up
had no baseline health insurance. There was no meaning-
ful impact on the results in all multivariate analyses. For
example, the estimate for lower income in the model
without asthma severity was nearly unchanged (OR, 1.2;
95% CI, 1.03–1.4).
Discussion
Asthma-related morbidity and mortality have risen sharply
in the USA since the late 1970s [2]. Hospitalization for
asthma, a potentially avoidable outcome, is an important
population-level marker of asthma severity. In this
prospective study of adults with continued access to
medical care for asthma, we identified two demographic
factors (low income and non-white race) that were asso-
ciated with a greater risk of hospitalization for asthma.
Reliance on the emergency department for urgent asthma
care was also associated with a greater risk of subse-
quent hospitalization. Greater asthma severity, as indi-
cated by recent asthma hospitalization and systemic
corticosteroid use, was related to an increased likelihood
of hospitalization.
Available online http://respiratory-research.com/content/2/1/053
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Table 3
Risk factors for hospitalization at 18-month longitudinal follow-up
Adjusted for all variables, except
Adjusted for all variables shown asthma severity and health status
Risk factor (OR [95% CI]) (OR [95% CI])
Demographic characteristics and smoking
Age (per 10 years) 1.2 (0.7–2.4) 1.2 (0.7–2.1)
Female gender 1.5 (0.5–4.6) 1.2 (0.5–2.8)
Non-white race (non-Hispanic) 3.1 (1.1–8.8) 1.9 (0.9–4.3)
Education (years) 0.8 (0.6–1.1) 0.9 (0.7–1.1)
Household income (per $10,000 decrement) 1.1 (0.9–1.3) 1.2 (1.02–1.4)
Current cigarette smoking 1.4 (0.2–7.9) 1.2 (0.3–4.6)
Past cigarette smoking 0.7 (0.2–2.0) 1.4 (0.6–3.3)
Asthma severity
Severity-of-asthma score (per 5 points) 3.4 (1.7–6.8) N/A
Recent hospitalizations for asthma 8.3 (2.1–33.4) N/A
Remote hospitalizations for asthma 2.7 (0.6–11.5) N/A
Other asthma clinical factors
Atopic history 0.7 (0.2–2.3) 0.5 (0.2–1.4)
Aspirin allergy history 0.7 (0.2–2.3) 1.7 (0.6–4.6)
Gastric acid suppression medication (in prior 12 months) 0.7 (0.2–2.0) 2.2 (1.0–4.9)
Health status
SF-36 Physical component score 0.98 (0.94–1.03) N/A
SF-36 Mental component score 0.97 (0.92–1.02) N/A
Health care access
Reliance on ED for urgent care 3.2 (1.0–9.8) 2.3 (1.0–5.7)
Multivariate analysis (n = 242). ED, emergency department; N/A, not applicable.Ecologic studies, based on US census data, have demon-
strated a strong inverse relationship between median
household income and hospitalization rates for asthma
[4–6,15,16]. Adults with asthma who live in lower income
geographic regions have higher rates of asthma hospitaliza-
tion, even after accounting for race and urbanicity [5]. Inves-
tigators have also observed a similar association between
community income level and mortality from adult asthma
[33–35]. Since these studies lack individual-level income
data, investigators have urged cautious interpretation [6].
The present study, using individual level data, supports the
association between lower household income and a greater
risk of hospitalization. The relationship between lower
income and hospitalization is less strong in the model
including asthma severity and health status, suggesting that
greater asthma severity may mediate this association.
The relationship between low income and asthma hospital-
ization has many potential explanations, including inade-
quate health care access. Low income persons in a
population-based survey were approximately three times
more likely to report difficulty paying for physician bills or
prescription drugs than those persons with higher income
[36]. Among adults hospitalized for asthma at a single insti-
tution, nearly one-third of low income subjects indicated no
usual source of outpatient asthma care at 3-month follow-
up [14]. In the present study, however, nearly all subjects
reported health insurance and access to ambulatory care
for asthma, making this an unlikely explanation. Moreover,
excluding subjects without baseline health insurance cov-
erage had no appreciable affect on the results.
Beyond health care access, the process of asthma care
may be less adequate among low income persons. Haas
et al found that, after admission to the hospital for asthma,
low income patients received lower intensity asthma man-
agement than those patients with higher income [14].
Another study demonstrated an association between a
surrogate marker of low income (unemployment) and high
daily beta agonist use [20], which is an established risk
factor for asthma hospitalization [37]. In a managed care
setting, which should ensure health care access, low
income asthma patients were less likely to visit an asthma
specialist [10]. Low income may alternatively be a marker
for other exacerbating factors, such as cockroach antigen
exposure [6,38], cigarette smoking, secondhand smoke
exposure [39], or viral upper respiratory infections.
African–American race has been associated with higher
hospitalization rates for asthma in both population-based
[2] and ecologic studies [4–7,15,16]. Socioeconomic
status and health care access, however, may confound
the relationship between race and hospitalization. Several
small-area analyses found higher asthma hospitalizations
rates among African–Americans, after statistically control-
ling for income [4,5,15]. Other analyses have found no
effect of race, after taking income into account [11]. In
children with access to health care through Medicaid,
investigators still observed higher hospitalization rates for
African–Americans with asthma [13]. African–American
asthma patients similarly had a greater risk of hospitaliza-
tion for asthma in managed care settings with access to
primary care [10,20]. Even after taking insurance status
into account, a national survey found a higher proportion
of African–Americans reporting difficulty affording medical
care than that of whites [36]. Our study suggests that the
increased risk of hospitalization for asthma among
African–Americans is not entirely explained by income,
education, or health care access, which were controlled
by design or analysis.
We also discovered a suggestion that persons of His-
panic race or ethnicity had a higher risk of hospitalization
for asthma compared with white, non-Hispanic adults. Pre-
vious studies focusing on Hispanic persons have provided
inconsistent findings. Studies from New York City and
Boston indicate that Hispanic persons are hospitalized
more frequently for asthma [4,6], whereas previous data
from California have not found an increased risk [5]. Other
studies have demonstrated a decreased morbidity and
mortality from asthma among Hispanic adults [40–42].
The heterogeneity of persons of Hispanic race or ethnicity
may explain these variable results.
Higher severity-of-asthma scores were associated with a
greater risk of hospitalization for asthma. On examining
disease-specific severity in more detail, we found that
recent asthma hospitalizations and systemic corticosteroid
use accounted for most of this increased risk, whereas
recent respiratory symptoms and other asthma medication
use were not predictive. In a recent analysis of adult health
maintenance organization members with asthma, systemic
steroid use and previous hospitalization were also associ-
ated with greater risk of hospitalization [21]. A study of
hospitalized asthma patients similarly found that both
factors were related to rehospitalization [43]. Neither
study, however, controlled for sociodemographic charac-
teristics, such as low income, that are associated with
hospitalization risk. In the present study, disease-specific
severity was associated with a greater risk of hospitaliza-
tion, controlling for other demographic, clinical, and health
care access factors.
Our findings differ from previous studies that found female
gender and current smoking as risk factors for asthma
hospitalization [9,39]. Female gender has not consistently
been related to hospitalization for asthma [44]. The lack of
association with smoking could be explained by the
‘healthy smoker effect’ [45]. According to this principle,
persons who develop smoking-related respiratory symp-
toms quit smoking, resulting in current smokers who are
less susceptible to acute effects of smoking.
Respiratory Research    Vol 2 No 1 Eisner et alPrevious studies evaluating the effect of GERD on asthma
morbidity have provided mixed results [46,47]. In the
present study, use of gastric acid suppression therapy, a
potential surrogate for GERD, was associated with a
greater risk of asthma hospitalization only in multivariate
analysis that did not control for asthma severity. This sug-
gests that increased asthma severity may function as a
causal intermediate between GERD (or related condi-
tions) and the increased likelihood of hospitalization for
asthma. Consistent with this finding, Levin et al found that
treatment of GERD with omeprazole improved asthma-
specific quality of life [30].
Because adults with asthma treated by specialists usually
have more severe asthma than those treated by generalist
physicians [25], our study results should be generalized to
the overall population of asthmatic persons with caution.
Although our sampling method attenuates confounding by
access to medical care for asthma, the results may not fully
apply to populations without health care access. Also
reflecting the sampling from specialty practices, study sub-
jects had a higher median household income and educa-
tional attainment than the general population. Even so, low
income was a risk factor for asthma hospitalization, sug-
gesting that our findings may be more broadly applicable.
The present study has additional limitations, including the
reliance on self-reported health care utilization. Socioeco-
nomic differences in recall or reporting of hospitalization,
for instance, could influence the risk model. Although we
were able to simultaneously consider demographic, clini-
cal, and severity-related covariates, the current study does
not fully elucidate the causal intermediates between pre-
dictors (eg income or race) and the risk of hospitalization.
Finally, our use of self-reported health insurance status
and source of regular asthma care may not fully ascertain
other, more subtle, barriers to effective asthma care. Previ-
ous work has demonstrated that health insurance status
does not fully explain health care-related financial prob-
lems [36]. Transportation difficulties, work-related
demands, and regional differences in health care quality
may also have impeded access to efficacious asthma
care. Despite these limitations, we believe the present
study results may be generalized to persons with moder-
ate to severe asthma.
Conclusion
Although the morbidity and mortality from asthma are
increasing in the USA and around the world, the minority
of adults with asthma will experience hospitalization or
death from asthma. Targeted interventions could poten-
tially benefit high-risk individuals in a cost-effective
manner. Our results suggest that simple demographic and
clinical features, especially low income, non-white race,
previous hospitalization history, systemic corticosteroid
use, and reliance on emergency department for urgent
asthma care, can identify such high-risk patients for more
intensive therapy.
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Supplementary material
Subject recruitment and retention
In brief, we recruited a random sample of certified Ameri-
can Board of Medical Specialty pulmonary specialists and
allergy/immunology specialists. The participating physi-
cians maintained a registry of persons aged 18–50 years
with outpatient visits for asthma over a prospective
4-week period. Each person registered by a participating
physician was contacted to arrange a telephone interview.
Risk factor variables
We ascertained household income as a series of incre-
ments (less than $5000, $5001–$10,000, $10,000
increments up to $50,000, $50,001–$75,000, and above
$75,000). To convert to specific income levels, the mid-
increment value was applied (except for the highest cate-
gory, where we used a value of $87,500).
The severity-of-asthma score systemic corticosteroid sub-
scale includes items for any past corticosteroid use, use
during the past 12 months, and steroid dependency. The
asthma medication subscale incorporates current use of
inhaled corticosteroids, inhaled non-steroidal anti-inflam-
matory agents, inhaled bronchodilators, oral beta agonists
and theophylline-containing medications, nasal medica-
tions (antihistamines, decongestants, and topical corticos-
teroids), and home nebulizer use. In this subscale, one
point is assigned for each medication used during the
past 2 weeks, with one additional point for frequent
inhaled beta agonist or corticosteroid use.
We measured generic health status using the Medical
Outcomes Study SF-36 questionnaire. Previous work
demonstrates the SF-36 instrument’s validity in adult
asthma [31]. The physical and mental component
summary scores have been defined from the eight SF-36
subscales by factor analysis [32], which measure physical
and mental dimensions of health, respectively. Each
summary score in the general US population has a mean
of 50 and a standard deviation of 10. Higher scores
reflect more favorable health states.
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